Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.

AHR ligands could treat inflammatory skin diseases.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Cadd4 effectively reduces cholesterol levels without side effects.

Breathing in newborn rats is affected differently by hormones based on their sex.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The new compound may be a safer alternative to finasteride for prostate protection.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.